10-K Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001759655-22-000032`
Period End Date	20211231
Filing Date	20220325
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	prva-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 54 Cash Flow Statement 101 Stockholders Equity 23

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$320.58M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	95.99M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.84M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$84.63M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$99.12M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$117.40M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	95.99M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$190.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$446.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.81M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$9.63M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.74M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.98M	USD	Point-in-time
Goodwill	`Goodwill`	$127.94M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$33.36M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$4.95M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.52M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.47M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$239.70M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$138.88M	USD	Point-in-time
Total assets	`Assets`	$328.97M	USD	Point-in-time
Total assets	`Assets`	$686.37M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$45.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$39.25M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$106.81M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$140.71M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$146.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$190.46M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.69M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$32.78M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$11.04M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$45.73M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$38.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$236.19M	USD	Point-in-time
Total liabilities	`Liabilities`	$185.32M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 107,837,741 and 95,985,817 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$1.08M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 107,837,741 and 95,985,817 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$960.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$633.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$165.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-208.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.88M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$146.75M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$426.87M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$23.31M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-3.10M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$328.97M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$686.37M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$786.36M	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$966.22M	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$817.08M	USD	Annual
Physician and practice expense	`PhysicianAndPracticeExpense`	$629.49M	USD	Annual
Physician and practice expense	`PhysicianAndPracticeExpense`	$622.63M	USD	Annual
Physician and practice expense	`PhysicianAndPracticeExpense`	$727.83M	USD	Annual
Cost of platform	`CostOfPlatform`	$174.73M	USD	Annual
Cost of platform	`CostOfPlatform`	$95.26M	USD	Annual
Cost of platform	`CostOfPlatform`	$105.01M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$9.16M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$22.75M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$11.34M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$44.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$41.83M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$255.88M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.43M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.46M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.84M	USD	Annual
Total operating expenses	`OperatingExpenses`	$770.30M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.18B	USD	Annual
Total operating expenses	`OperatingExpenses`	$791.70M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$25.38M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$-217.44M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$16.06M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-6.91M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-1.07M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-1.92M	USD	Annual
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$23.46M	USD	Annual
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-218.51M	USD	Annual
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.15M	USD	Annual
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-7.44M	USD	Annual
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-27.86M	USD	Annual
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$1.21M	USD	Annual
Net (loss) income	`ProfitLoss`	$30.90M	USD	Annual
Net (loss) income	`ProfitLoss`	$-190.65M	USD	Annual
Net (loss) income	`ProfitLoss`	$7.95M	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-340.00K	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.42M	USD	Annual
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-299.00K	USD	Annual
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-188.23M	USD	Annual
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$31.24M	USD	Annual
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$8.24M	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.09	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.33	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.83	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.83	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	Annual
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.33	USD	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.95M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.93M	shares	Annual
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.95M	shares	Annual
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.93M	shares	Annual

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$30.90M	USD	Annual
Net income (loss)	`ProfitLoss`	$-190.65M	USD	Annual
Net income (loss)	`ProfitLoss`	$7.95M	USD	Annual
Depreciation	`Depreciation`	$1.15M	USD	Annual
Depreciation	`Depreciation`	$1.19M	USD	Annual
Depreciation	`Depreciation`	$784.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$643.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$642.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.31M	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$157.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$332.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$134.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$484.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$207.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$253.53M	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-7.83M	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$716.00K	USD	Annual
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-28.41M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.18M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.64M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.78M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$151.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$962.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.27M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.43M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.19M	USD	Annual
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$9.68M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.08M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.26M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$9.71M	USD	Annual
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$24.54M	USD	Annual
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$15.57M	USD	Annual
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$33.90M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$13.94M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$4.84M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.54M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$672.00K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$24.36M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$38.89M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$55.06M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$547.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$380.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.71M	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$32.23M	USD	Annual
Business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-380.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.71M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-32.77M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.69M	USD	Annual
Note payable to affiliate	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Note payable to affiliate	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Note payable to affiliate	`RepaymentsOfRelatedPartyDebt`	$15.25M	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$30.00M	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$875.00K	USD	Annual
Repayment of note payable	`RepaymentsOfNotesPayable`	$875.00K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	$35.00M	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$3.83M	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$108.00K	USD	Annual
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$287.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$618.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$10.00M	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	$10.00M	USD	Annual
Line of credit payments	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$213.66M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-767.00K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-10.87M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$7.78M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.74M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$235.94M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$1.93M	USD	Annual
Interest paid	`InterestPaidNet`	$888.00K	USD	Annual
Interest paid	`InterestPaidNet`	$9.20M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$381.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$504.00K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$316.00K	USD	Annual
Conversion of notes payable to related parties to capital contribution	`NoncashInvestingAndFinancingActivitiesConversionOfNotesPayableToRelatedPartiesToCapitalContribution`	-	USD	Annual
Conversion of notes payable to related parties to capital contribution	`NoncashInvestingAndFinancingActivitiesConversionOfNotesPayableToRelatedPartiesToCapitalContribution`	$13.26M	USD	Annual
Conversion of notes payable to related parties to capital contribution	`NoncashInvestingAndFinancingActivitiesConversionOfNotesPayableToRelatedPartiesToCapitalContribution`	$4.70M	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Capital contribution	`AdjustmentsToAdditionalPaidInCapitalCapitalContribution`	$4.70M	USD	Annual
Capital contribution	`AdjustmentsToAdditionalPaidInCapitalCapitalContribution`	$13.26M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$207.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$253.53M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$484.00K	USD	Annual
Net income (loss)	`ProfitLoss`	$30.90M	USD	Annual
Net income (loss)	`ProfitLoss`	$-190.65M	USD	Annual
Net income (loss)	`ProfitLoss`	$7.95M	USD	Annual
Stock option exercise (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.94M	shares	Annual
Stock option exercise	`StockIssuedDuringPeriodValueStockOptionsExercised`	$108.00K	USD	Annual
Issuance of common stock upon closing of initial public offering (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	9.72M	shares	Annual
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)	`StockIssuedDuringPeriodSharesShareBasedCompensation`	2.13M	shares	Annual
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.83M	USD	Annual
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$28.82M	USD	Annual
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$86.04M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.